Pharmaceutical Sciences and Innovations in Pharma Industry

Pharmaceutical Nanotechnology

Drug particles in the nanometer size range have unique characteristics that can lead to enhanced performance in a variety of dosage forms. Formulated correctly, particles in this size range are resistant to settling and can have higher saturation solubility, rapid dissolution, and enhanced adhesion to biological surfaces, thereby providing a rapid onset of therapeutic action and improved bioavailability. Scientists at Cirrus Pharmaceuticals, Inc. use nanotechnology to approach classical and novel drug delivery applications. We provide services for producing, formulating, and characterizing nanoparticles for a wide array of applications including, but not limited to, oral, pulmonary and parenteral delivery. Pharmaceutical Nanotechnology deals with emerging new technologies for developing customized solutions for drug delivery systems. 

The worldwide theranostic nanomaterial market was evaluated to add up to about $16 billion in 2011 and $112 billion in 2012. The market ought to add up to about $188 bil0lion by 2017, and have a five-year compound yearly development rate (CAGR) of 10.8%.